Page last updated: 2024-10-29

iohexol and Cancer of Parotid

iohexol has been researched along with Cancer of Parotid in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"The TDC of basal cell adenomas had a fast ascension followed by a plateau, then a gradual descent."1.40Diagnostic value of CT perfusion imaging for parotid neoplasms. ( Dong, Y; Ge, Y; Lei, GW; Wang, SW; Wei, FC; Zheng, SW, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, Y1
Lei, GW1
Wang, SW1
Zheng, SW1
Ge, Y1
Wei, FC1
Jin, GQ1
Su, DK1
Xie, D1
Zhao, W1
Liu, LD1
Zhu, XN1

Other Studies

2 other studies available for iohexol and Cancer of Parotid

ArticleYear
Diagnostic value of CT perfusion imaging for parotid neoplasms.
    Dento maxillo facial radiology, 2014, Volume: 43, Issue:1

    Topics: Adenolymphoma; Adenoma; Adenoma, Pleomorphic; Adult; Aged; Aged, 80 and over; Blood Volume; Capillar

2014
Distinguishing benign from malignant parotid gland tumours: low-dose multi-phasic CT protocol with 5-minute delay.
    European radiology, 2011, Volume: 21, Issue:8

    Topics: Adenolymphoma; Adenoma, Pleomorphic; Adult; Aged; Analysis of Variance; Contrast Media; Diagnosis, D

2011